Located northwest of the Twin Cities in Anoka, Minn., the facility has more than 60,000 square feet of design, development, and manufacturing space. Additionally, the facility has more than 18,000 square feet of clean-room space for manufacturing and assembly of all classes of medical devices from disposables to implantable products. Specific sections of the building are also dedicated to silicone molding and 3-D-printing capabilities.
“It’s wonderful to see the significant investment made by JunoPacific in the continually growing medical device expertise here in the Minneapolis area,” Paulsen said. “It is a pleasure to participate in recognizing this significant milestone for the community and for JunoPacific.”
Paulsen has been a champion of medical device tax repeal efforts in the House of Representatives and one of the medical device industry’s most vocal advocates.
The new facility currently employs more than 125 people and is expected to grow by 25 to 50 percent in the next two years, according to JunoPacific officials . JunoPacific also has three other facilities in the Midwest and West Coast.
“We are excited to celebrate the opening of this new facility with our dedicated team members and valued clients, and are greatly appreciative of Congressman Erik Paulsen’s support of the medical device industry,” said JunoPacific President Kern Bhugra. “We look forward to leveraging the state-of-the-art capabilities of this facility, along with the medical device expertise provided by our teams here in the Twin Cities and in Silicon Valley, to further enhance the delivery of medical device solutions for our clients.”
The open house was also celebrated by executives from Cretex Companies Inc. JunoPacific is part of the Cretex Medical group of companies which provide turn-key injection molding, precision machining, stamping, assembly and engineering services for the medical device industry. Cretex Medical is made up of five medical device engineering and contract manufacturing firms: JunoPacific, RMS, RMS Surgical, Meier, and Spectralytics.
“It is great to see the increased momentum that this new facility brings to JunoPacific and to the breadth of capabilities provided by our Cretex Medical companies,” said Lynn Schuler, Cretex president and CEO.